Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Megalestari Epack Sentosaraya Tbk. (EPAC) vs Indofarma Tbk. (INAF) Price & Performance

Megalestari Epack Sentosaraya Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

Megalestari Epack Sentosaraya Tbk. vs Indofarma Tbk. — how do they compare? Megalestari Epack Sentosaraya Tbk. trades at Rp55 (market cap 181.69B, 23.97M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Indofarma Tbk. is far larger — about 2.1× Megalestari Epack Sentosaraya Tbk.'s market cap. Which is the better fit depends on your goals.

EPACINAF
Market Cap
181.69B390.51B
Volume
23.97M
Lot
239.69K
Turnover
1.29B
Average Price
53.97
Value
1.29B
Indicative Equilibrium Price
55
Indicative Equilibrium Volume
3.42K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EPAC
View details
INAF
View details

About Megalestari Epack Sentosaraya Tbk.

PT Megalestari Epack Sentosaraya Tbk ("Company") formerly PT Era Prima Adi Cipta Kreasindo and its subsidiaries (together the "Group") was established based on the Deed No.55, dated June 18, 2013 of Poppie Savitri Martosuhardjo Pharmanto, S.H., notary in Jakarta.

Read more on EPAC

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF